ISSN: 2150-7740

Journal Home

Journal Guideline

AJOB Neuroscience Q2 Unclaimed

Taylor and Francis Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

AJOB Neuroscience is a journal indexed in SJR in Neuroscience (miscellaneous) with an H index of 34. It has an SJR impact factor of 0,841 and it has a best quartile of Q2. It has an SJR impact factor of 0,841.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Neuroscience (miscellaneous) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,841

SJR Impact factor

34

H Index

70

Total Docs (Last Year)

260

Total Docs (3 years)

1203

Total Refs

292

Total Cites (3 years)

35

Citable Docs (3 years)

1.28

Cites/Doc (2 years)

17.19

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

European Journal of Neuroscience Q2
Journal of Comparative Neurology Q2
Frontiers in Neuroscience Q2
Brain Research Bulletin Q2
Neuroscience Q2

Compare this journals

Aims and Scope

Best articles by citations

They Might Retain Capacities to Consent But Do They Even Care?

Neuromarketing and AI - Powerful Together, but Needing Scrutiny

"Cerebral Communication" With Patients With Disorders of Consciousness: Clinical Feasibility and Implications

Neuroimaging Can Be Useful in the Hand of Neutral Experts Ordered by the Court

Data as a Cross-Cutting Dimension of Ethical Importance in Direct-to-Consumer Neurotechnologies

Response to Open Peer Commentaries on "Ethical Dimensions of Direct-to-Consumer Neurotechnologies"

Compatibilist Free Will: The Necessary Elements and Their Importance

Empathy Is Just One Component of Moral Character

DBS for Depression? Lessons From Patients' Beliefs for Research, Treatment, and Noninvasive Brain Modulation

We Can Make Room for SSRIs

Deep Brain Stimulation for Parkinson's Disease: A Critique of Principlism as a Framework for the Ethical Analysis of the Decision-Making Process

Alienation, Quality of Life, and DBS for Depression

SHOW MORE ARTICLES

Daubert, Frye and DTI: Hijacking the Right to Trial by Jury

The Social Brain: Deriving an Ought From an Is and the Future of Moral Reasoning

Neuroimaging in the Courtroom: Normative Frameworks and Consensual Practices

Deep Brain Stimulation in Parkinsonian Patients - Ethical Evaluation of Cognitive, Affective, and Behavioral Sequelae

Deep Brain Stimulation in Parkinsonian Patients - Implications for Trialing DBS in Intractable Psychiatric Disorders

Empathy, Justice, and Moral Behavior

Deep Brain Stimulation, Emotions, and Decision-Making Capacity

"Could Have Chosen Otherwise Under Identical Conditions": An Evolutionary Perspective on Free Will

Ethical Perspectives on Neuromarketing: An Interview With Will Allred

Neuroimaging, Expert Witnesses, and Ethics: Convergence and Conflict in the Courtroom

Narratives of DBS

Who Should Hold the Remote for the New Me? Cognitive, Affective, and Behavioral Side Effects of DBS and Authentic Choices Over Future Personalities